Becton, Dickinson and Company $BDX Shares Acquired by Fort Washington Investment Advisors Inc. OH

Fort Washington Investment Advisors Inc. OH lifted its holdings in Becton, Dickinson and Company (NYSE:BDX) by 11.2% in the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 887,913 shares of the medical instruments supplier’s stock after purchasing an additional 89,559 shares during the period. Becton, Dickinson and Company makes up 0.9% of Fort Washington Investment Advisors Inc. OH’s holdings, making the stock its 25th biggest holding. Fort Washington Investment Advisors Inc. OH owned approximately 0.31% of Becton, Dickinson and Company worth $152,943,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in BDX. Brighton Jones LLC lifted its stake in Becton, Dickinson and Company by 98.2% in the fourth quarter. Brighton Jones LLC now owns 1,770 shares of the medical instruments supplier’s stock worth $401,000 after acquiring an additional 877 shares during the last quarter. Centaurus Financial Inc. increased its stake in Becton, Dickinson and Company by 5.6% in the 4th quarter. Centaurus Financial Inc. now owns 1,444 shares of the medical instruments supplier’s stock valued at $328,000 after buying an additional 77 shares during the period. Wealth Enhancement Advisory Services LLC increased its stake in Becton, Dickinson and Company by 22.2% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 54,529 shares of the medical instruments supplier’s stock valued at $12,371,000 after buying an additional 9,892 shares during the period. MassMutual Private Wealth & Trust FSB increased its stake in Becton, Dickinson and Company by 39.1% in the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 815 shares of the medical instruments supplier’s stock valued at $187,000 after buying an additional 229 shares during the period. Finally, First Hawaiian Bank grew its stake in shares of Becton, Dickinson and Company by 27.0% during the 1st quarter. First Hawaiian Bank now owns 4,298 shares of the medical instruments supplier’s stock worth $984,000 after purchasing an additional 913 shares during the period. Institutional investors and hedge funds own 86.97% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently commented on BDX. Wall Street Zen upgraded shares of Becton, Dickinson and Company from a “hold” rating to a “buy” rating in a research report on Saturday, August 9th. Wells Fargo & Company increased their price objective on shares of Becton, Dickinson and Company from $172.00 to $184.00 and gave the stock an “equal weight” rating in a report on Friday, August 8th. Morgan Stanley increased their price objective on shares of Becton, Dickinson and Company from $196.00 to $197.00 and gave the stock an “overweight” rating in a report on Monday, August 11th. Royal Bank Of Canada assumed coverage on shares of Becton, Dickinson and Company in a report on Thursday. They issued a “sector perform” rating and a $211.00 price target on the stock. Finally, Argus increased their price objective on shares of Becton, Dickinson and Company from $220.00 to $230.00 in a research report on Monday, September 15th. Four equities research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $213.09.

Insider Activity

In related news, Director Claire Fraser sold 917 shares of the business’s stock in a transaction that occurred on Wednesday, September 10th. The stock was sold at an average price of $187.50, for a total value of $171,937.50. Following the completion of the sale, the director owned 22,226 shares of the company’s stock, valued at approximately $4,167,375. The trade was a 3.96% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Michael David Garrison sold 1,185 shares of the business’s stock in a transaction that occurred on Friday, July 18th. The shares were sold at an average price of $180.29, for a total value of $213,643.65. Following the completion of the sale, the executive vice president directly owned 4,887 shares of the company’s stock, valued at approximately $881,077.23. The trade was a 19.52% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 2,965 shares of company stock worth $551,536. Company insiders own 0.36% of the company’s stock.

Becton, Dickinson and Company Price Performance

Shares of NYSE BDX opened at $184.59 on Friday. Becton, Dickinson and Company has a fifty-two week low of $163.33 and a fifty-two week high of $251.99. The firm’s 50-day simple moving average is $188.27 and its 200 day simple moving average is $188.72. The company has a quick ratio of 0.62, a current ratio of 1.10 and a debt-to-equity ratio of 0.69. The stock has a market cap of $52.91 billion, a P/E ratio of 33.20, a P/E/G ratio of 1.49 and a beta of 0.27.

Becton, Dickinson and Company (NYSE:BDX) last issued its quarterly earnings results on Thursday, August 7th. The medical instruments supplier reported $3.68 EPS for the quarter, topping the consensus estimate of $3.40 by $0.28. Becton, Dickinson and Company had a net margin of 7.51% and a return on equity of 16.23%. The firm had revenue of $5.51 billion for the quarter, compared to analysts’ expectations of $5.50 billion. During the same period in the previous year, the business earned $3.50 earnings per share. Becton, Dickinson and Company’s revenue for the quarter was up 10.4% compared to the same quarter last year. Becton, Dickinson and Company has set its FY 2025 guidance at 14.300-14.450 EPS. Equities analysts expect that Becton, Dickinson and Company will post 14.43 EPS for the current year.

Becton, Dickinson and Company Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Monday, September 8th will be paid a dividend of $1.04 per share. This represents a $4.16 annualized dividend and a yield of 2.3%. The ex-dividend date of this dividend is Monday, September 8th. Becton, Dickinson and Company’s payout ratio is 74.82%.

About Becton, Dickinson and Company

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.